Enzymatic synthesis of chiral intermediates for pharmaceuticals

Journal of Industrial Microbiology and Biotechnology

Volumn 30, Issue 5, 2003, Pages 252-259

  Patel, Ramesh ^a   Hanson, Ronald ^a   Goswami, Animesh ^a   Nanduri, Venkata ^a   Banerjee, Amit ^a   Donovan, Mary Jo ^a   Goldberg, Steven ^a   Johnston, Robert ^a   Brzozowski, David ^a   Tully, Thomas ^a   Howell, Jeffrey ^a   Cazzulino, Dana ^a   Ko, Rapheal ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

3 receptors agonists; Antihypertensive; Biocatalysis; Chiral intermediates; Melatonin receptor agonists

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; MELATONIN RECEPTOR; OMAPATRILAT;

BIOTRANSFORMATION; CHIRALITY; CONFERENCE PAPER; DRUG ACTIVITY; DRUG INDUSTRY; DRUG SYNTHESIS; ENANTIOSELECTIVITY; ENZYME SYNTHESIS; MICROBIOLOGY; MICROORGANISM; PHARMACEUTICS;

ADRENERGIC BETA-AGONISTS; ANTIHYPERTENSIVE AGENTS; BIOTRANSFORMATION; CHEMISTRY, PHARMACEUTICAL; ENZYMES; RECEPTORS, ADRENERGIC, BETA-3; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; STEREOISOMERISM;

EID: 0038638237     PISSN: 13675435     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10295-003-0032-6     Document Type: Conference Paper

References (32)

1. Arch J (1997) β3-adrenoceptors and other putative atypical β-adrenoceptors. Pharmacol Rev Commun 9:141-148
2. Archelas A, Furstoss R (1999) Biocatalytic approaches for the synthesis of enantiopure epoxides. Topics Curr Chem 200:159-191
3. Bloom J, Datta M, Johnson B, Wissner A, Bruns M, Largis E, Dolan J, Claus T (1989) Disodium (R,R)5-2-(3-chlorophenyl)-2-hydroxyethyl [amino]propyl-1,3-benzodioxole-2,2-dicarboxylate. A potent β-adrenergic agonist virtually specific for β3 receptors. J Med Chem 35:3081-3084
4. Buckland B, Robinson DK, Chartrain M (2000) Biocatalysis for pharmaceuticals: status and prospects for a key technology. Metab Eng 2:42-48
5. Catt J, Johnson G, Keavy D, Mattson R, Parker M, Takaki K, Yevich J (1999) Preparation of benzofuran and dihydrobenzofuran melatonergic agents. US 5856529, CAN 130:110151
6. Fantin G, Fogagnolo M, Medici A, Pedrini A, Fontana S (2000) Kinetic resolution of racemic secondary alcohols via oxidation with Yarrowia lipolytica strains. Tetrahedron: Asymm 11:2367-2373
7. Fisher L, Sher P, Skwish S, Michael I, Seiler S, Dickinson K (1994) BMS-187257, a potent, selective, and novel heterocyclic β-3 adrenergic receptor agonist. Bioorg Med Chem Lett 6:2253-2258
8. Food and Drug Administration (1992) FDA's statement for the development of new stereoisomeric drugs. Chirality 4:338-340
9. Goswami A, Totleben M, Singh A, Patel R (1999) Stereospecific enzymatic hydrolysis of racemic epoxide: a process for making chiral epoxide. Tetrahedron: Asymm 10:3167-3175
10. Goswami A, Mirfakhrae K, Patel R (1999) Deracemization of racemic 1,2-diol by biocatalytic stereoinversion. Tetrahedron: Asymm 10:4239-4244
11. Gotor V (2000) Pharmaceuticals through enzymatic transesterification and enzymatic aminolysis reactions. Biocat Biotrans 2000;18:87-103
12. Hanson R, Schwinden M, Banerjee A, Brzozowski D, Chen B-C, Patel B, McNamee C, Kodersha G, Kronenthal D, Patel R, Szarka L (1999) Enzymatic synthesis of L-6-hydroxynorleucine. Bioorg Med Chem 7:2247-2252
13. Hanson R, Howell J, LaPorte T, Donovan M, Cazzulino D, Zannella V, Montana M, Nanduri V, Schwarz S, Eiring R, Durand S, Wasylyk J, Parker L, Liu M, Okuniewicz F, Chen B-C, Harris J, Natalie K, Ramig K, Swaminathan S, Rosso V, Pack S, Lotz B, Bernot P, Rusowicz A, Lust D, Tse K, Venit J, Szarka L, Patel R (2000) Enzymatic synthesis of allysine ethylene acetal. Enzyme Microb Technol 26:348-358
14. Hou CT, Patel R, Laskin A, Barnabe N (1982) NAD-linked formate dehydrogenase from methanol-grown Pichia pastoris NRRL-Y-7556. Arch. Biochem. Biophys 216:296-305
15. Kragl U, Vasic-Racki D, Wandrey C (1992) Continuous processes with soluble enzymes. Chem Eng Tech 64:499-509
16. Mahmoudian M (2000) Biocatalytic production of chiral pharmaceutical intermediates. Biocat Biotrans 18:105-116
17. Mischitz M, Kroutil W, Wandel U, Faber K (1995) Asymmetric microbial hydrolysis of epoxides. Tetrahedron: Asymm 6:1261-1272
18. O'Brien M, Vanasse B (2000) Asymmetric processes in the large-scale preparation of chiral drug candidates. Curr Opin Drug Discov Dev 3:793-806
19. Patel R, Banerjee A, Chu L, Brzozowski D, Nanduri V, Szarka L (1998) Microbial synthesis of chiral intermediates for β-3-receptor agonists. J Am Oil Chem Soc 75:1473-1482
20. Patel R (1999) Microbial/enzymatic synthesis of chiral drug intermediates. Adv App Microbiol 43:91-140
21. Patel R (2000) Stereoselective biocatalysis for synthesis of some chiral pharmaceutical intermediates. In: Patel R (ed) Stereoselective biocatalysis. Marcel Dekker, New York, pp 87-130
22. Patel R, Banerjee A, Nanduri V, Goldberg S, Johnston R, Hanson R, McNamee C, Brzozowski D, Tully T, Ko R, LaPorte T, Cazzulino D, Swaminathan S, Parker L, Venit J (2000) Biocatalytic preparation of a chiral synthon for a vasopeptidase inhibitor: Enzymatic conversion of N2-{N-(phenylmethoxy)carbonyl]L-homocysteinyl]-L-lysine (1 < 1′)-disulfide to 4S-(4α,7α,10ab)]1-octahydro-5-oxo-4-(phenylmethoxy) carbonyl]amino]-7H-pyrido-2,1-b]1,3]thiazepin-7-carboxylic acid methyl ester by a novel L-lysine ε-aminotransferase. Enzyme Microb Technol 27:376-389
23. Patel R. Enzymatic synthesis of chiral intermediates for Omapatrilat, an antihypertensive drug. (2001). Biomol Eng 17:167-182
24. Pesti J, Dicosimo R (2000) Recent progress in enzymatic resolution and desymmetrization of pharmaceuticals and their intermediates. Curr Opin Discov Dev 3:764-778
25. Robl J, Sun C, Stevenson J, Ryono D, Simpkins L, Cimarusti M, Dejneka T, Slusarchyk W, Chao S, Stratton L, Misra R, Bednarz M, Asaad M, Cheung H, Aboa-Offei B, Smith P, Mathers P, Fox M, Schaeffer T, Seymour A, Trippodo N (1997) Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. J Med Chem 40:1570-1577
26. Rumbero A, Martin J, Lumbreras M, Liras P, Esmahan C (1995) Chemical synthesis of allysine ethylene acetal and conversion in situ into 1-piperideine-6-carboxylic acid: key intermediate of the α-aminoadipic acid for β-lactam antibiotics biosynthesis. Bioorg Med Chem 3:1237-1240
27. Schütte H, Flossdorf J, Sahm H, Kula M-R (1976) Purification and properties of formaldehyde dehydrogenase and formate dehydrogenase from Candida boidinii. Eur J Biochem 62:151-160
28. Seymour A, Swerdel J, Abboa-Offei B (1991) Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme. J Cardiovasc Pharmacol 17:456-465
29. Stecher H, Faber K (1997) Biocatalytic deracemization techniques. Dynamic resolutions and stereoinversions. Synthesis 1:1-16
30. Stewart D (2001) Dehydrogenases and transaminases in asymmetric synthesis. Curr Opin Chem Biol 5:120-129
31. Wichman R, Wandrey C, Bueckmann A, Kula M-R (1981) Continuous enzymic transformation in an enzyme membrane reactor with simultaneous NAD(H) regeneration. Biotechnol Bioeng 23:2789-2802
32. Zak A (2001) Industrial biocatalysis. Curr Opin Chem Biol 5:130-136